Patents
Patents for C07H 5 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium (3,671)
06/2005
06/23/2005WO2005056783A1 Catalytic domains of beta(1,4)-galactosyltransferase i having altered metal ion specificity
06/23/2005WO2005056525A2 Deacetylation of n-acetylglucosamine
06/23/2005US20050136485 Iterative one-pot oligosaccharide synthesis
06/16/2005WO2005007076B1 Colchicine derivatives
06/16/2005US20050130908 Treatment or amelioration of depression; provides better bioavailability
06/15/2005EP1539962A1 Polyene polyketides and methods of production
06/15/2005EP1539780A1 Derivatives of monosaccharides for drug discovery
06/09/2005US20050124559 Antimicrobial agent
06/08/2005CN1623996A N-acyl amino glucose and its preparation process
06/02/2005US20050119474 Geranyl compounds
06/02/2005US20050119469 Saccharide sulfation methods
06/01/2005EP1534324A2 Tumor specific oligosaccharide epitopes and use thereof
05/2005
05/25/2005EP1458732B1 Method for preparing a glucosamine compound, and compound thus obtained
05/24/2005US6897326 Asymmetrical bicipital lipid and tubular aggregate formed by using the same
05/24/2005US6897198 Method of treatment with combinations of statin and aryl-substituted propanolamine derivatives
05/19/2005WO2005044832A1 Process for the preparation of 1-chloro-3,5-di-o-acyl-2-deoxy-l-ribofuranoside derivatives
05/19/2005WO2005044758A1 Process for producing radioactive-fluorine-labeled compound
05/19/2005WO2005024025A8 Polyene polyketides and methods of production
05/19/2005WO2004080409A3 Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus
05/19/2005US20050107600 Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor
05/19/2005CA2545437A1 Process for the preparation of 1-chloro-3,5-di-o-acyl-2-deoxy-l-ribofuranoside derivatives
05/17/2005US6894160 Converting sugars such as glucose and fructose into industrial useful products via hydrogenation and reductive amination using platinum catalyst formed from stabilized nanoparticles
05/12/2005WO2004063209A3 Methods of producing c-aryl glucoside sglt2 inhibitors
05/12/2005US20050101642 Niacinamide derivatives as inhibitor of poly(ADP-ribose)polymerase; ranitidine, cimetidine, famotidine, nizatidine as gastric acid secretion control; immunomodulation and suppression of hypersensitivity and inflammatory reaction; IgE mediated allergic reaction; no side effects; virtually non-toxic
05/12/2005US20050100611 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors
05/10/2005US6890581 Methods for buffer stabilized aqueous deacylation
05/10/2005CA2222995C Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides
05/04/2005CN1612857A Geranyl compounds
04/2005
04/28/2005US20050090655 synthesizing an O-glycan among the glycoprotein-type sugar chains using a saccharide primer in cells
04/27/2005CN1610690A Method for preparing a glucosamine compound, and compound thus obtained
04/21/2005CA2540586A1 Treatment of a condition in a mammal with administration of aminosugar and uses thereof
04/20/2005CN1197839C Stibene derivative organic amine salt, its preparation method, use and medicinal composition
04/13/2005EP1521762A2 Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor
04/13/2005EP1347986B1 Crystalline glucosamine sulphate metal salts and processes for preparing the same
04/12/2005US6878819 Oligosaccharides or oligosaccharide containing compounds, especially N-acetyl-chitooligosaccharides, which are fucosylated with donar nucleotide sugar containing L-fucose such as guanosine diphosphate-L-fucose
04/07/2005WO2005030677A1 Process for producing radioactive fluorine compound
04/07/2005WO2005007076A3 Colchicine derivatives
04/05/2005US6875861 Process for producing nitrosonium ions
04/05/2005US6875451 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
03/2005
03/31/2005WO2005028490A1 Halogenated deoxy-glucose labeled targeting molecules
03/31/2005US20050069584 Diphenhydramine tannate solid dose compositions and methods of use
03/23/2005CN1599747A Isolation of lectins
03/17/2005WO2004075843A3 Glycosolated enkephalin agents
03/17/2005WO2004064754A3 Bioadhesive pharmaceutical compositions
03/17/2005US20050059814 Alkylated c-sugars and uses thereof
03/09/2005EP1412346B1 Method for producing novel spinosyn derivatives
03/09/2005EP0831847B1 Method of synthesis of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions
03/09/2005CN1590395A New type azesaccharide compound, their synthesis method and use as immune inhibitor and glycocidase inhibitor
03/03/2005US20050049221 algins are reduced or eliminated; apoptosis-inducing food or beverage; organoleptic
03/02/2005EP1509254A1 New agents for magnetic imaging method
03/02/2005EP0836609B1 Method and device for synthesising labelled compounds
02/2005
02/24/2005US20050042734 incubation of starches, maltodextrins or glycogen with an ammonium source in a reaction mixture contaiinig cell extracts comprising glucosamine-6-phosphate deaminase activity, to form glucosamine-6-phosphate
02/22/2005US6858233 Simmondsin processing methods and products
02/17/2005US20050037980 Substituted fused heterocyclic C-glycosides
02/16/2005EP1506213A1 An antimicrobial agent
02/16/2005EP1506212A2 Novel substituted sulfamate anticonvulsant derivatives
02/14/2005WO2005024025A1 Polyene polyketides and methods of production
02/10/2005WO2005012319A1 Production of 2-18f-2-deoxy-d-glucose via solid-phase synthesis
02/10/2005WO2005012318A2 Substituted fused heterocyclic c-glycosides
02/10/2005WO2004032826A8 Process for preparing tannate tablet capsule or other solid dosage forms
02/10/2005CA2549015A1 Substituted fused heterocyclic c-glycosides
02/09/2005CN1188134C Preparation having increased in vivo tolerability
01/2005
01/27/2005WO2005007076A2 Colchicine derivatives
01/27/2005CA2521990A1 Colchicine derivatives
01/26/2005EP1001961B1 Substituted tetrahydropyrane derivatives and method for producing same
01/26/2005CN1185957C Skin-care agent, health and face-care foodstuff
01/20/2005WO2005005485A1 Chitin oligomer composition and/or chitosan oligomer composition, and process for producing the same
01/20/2005US20050014720 using electrodialysis to prepare glucosamine hydroiodide, glucosamine pyruvate, glucosamine phosphate or their mixtures with glucosamine hydrochloride; for treating osteoarthritis in animals
01/20/2005US20050014718 Tumor specific oligosaccharide sequences and use thereof
01/20/2005US20050013922 Sucralose composition
01/20/2005CA2507017A1 Chitin oligomer composition and/or chitosan oligomer composition, and process for producing the same
01/19/2005EP1496896A1 Inhibitors of akt activity
01/19/2005EP1418929A4 Simmondsin processing methods and products
01/13/2005US20050009765 Heterodimeric conjugates of neomycin-chloramphenicol having an enhanced specificity against rna targets and its preparation
01/11/2005US6841536 Prodrugs and conjugates of thiol- and selenol-containing compounds and methods of use thereof
01/06/2005WO2005000862A2 Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
01/06/2005CA2529341A1 Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
01/05/2005EP1493736A1 Prodrugs and conjugates of selenol-containing compounds and methods of use thereof
01/05/2005EP1492802A1 Methods for buffer stabilized aqueous deacylation
01/05/2005EP1492801A1 Methods and compositions for altering the sweetness delivery profile of sucralose
12/2004
12/30/2004US20040267007 Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors and intermediates therefor
12/23/2004WO2004111188A2 Process for the treatment of chitinaceous materials and for the deacetylation of chitin
12/23/2004US20040259840 Using phosphoglycerides, lipid having sphingosine base, glycerides and sterol; wound healing agents; atherosclerosis
12/22/2004EP1487846A1 Process for improving sucralose purity and yield
12/22/2004EP1487812A1 Anomeric derivatives of monosaccharides
12/22/2004EP1487763A2 Use of microfabricated devices for radiosynthesis
12/22/2004EP1487460A2 Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof
12/22/2004CN1556802A Method for producing novel spinosyn derivatives
12/21/2004US6833130 Recombinant microorganisms expressing an oligosaccharide receptor mimic
12/15/2004EP1485388A2 Topiramate salts and compositions comprising and methods of making and using the same
12/15/2004CN1554662A Process for preparing high purity acarbose
12/14/2004US6831173 Process for selective oxidation of primary alcohols and novel carbohydrate aldehydes
12/09/2004WO2004031396A3 Cell-free production of glucosamine
12/09/2004US20040247523 Diagnosing and localizing sites of inflammation and perfusion abnormalities (e.g. reperfusion injury, vulnerable plaque, bacterial endocarditis or cardiac transplant rejection) in a single dual isotope imaging procedure, particularly CT imaging, ultrasound, or scintigraphy.
12/08/2004EP1483278A1 Extractive methods for purifying sucralose
12/08/2004EP1483253A1 An antimicrobial agent
12/02/2004WO2004104016A1 Process for the preparation of 4, 1', 6'-trichloro-4, 1', 6'­trideoxygalactosucrose
12/02/2004WO2004093867A3 Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use
12/02/2004US20040242858 Contacting derivatives with microorganism (Actinomycetes or Streptomyces), or enzyme extract therefrom, in aqueous nutrient medium under aerobic conditions; biological pest control and crop protection
11/2004
11/30/2004US6825236 Colchicine derivatives
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 37